Nom du produit:[2-(2,6-dioxo-3-piperidyl)-3-oxo-isoindolin-5-yl]methyl N-[2-fluoro-4-methyl-5-(trifluoromethoxy)phenyl]carbamate

IUPAC Name:[2-(2,6-dioxopiperidin-3-yl)-3-oxo-2,3-dihydro-1H-isoindol-5-yl]methyl N-[2-fluoro-4-methyl-5-(trifluoromethoxy)phenyl]carbamate

CAS:2803881-73-2
Formule moléculaire:C23H19F4N3O6
Pureté:95%
Numéro de catalogue:CM1076470
Poids moléculaire:509.41

Unité d'emballage Stock disponible Prix($) Quantité
CM1076470-100mg in stock ũũǜǶ
CM1076470-250mg in stock ũưǶƦ
CM1076470-500mg in stock Ⱥưũũ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:2803881-73-2
Formule moléculaire:C23H19F4N3O6
Point de fusion:-
Code SMILES:CC1=C(OC(F)(F)F)C=C(NC(=O)OCC2=CC=C3CN(C4CCC(=O)NC4=O)C(=O)C3=C2)C(F)=C1
Densité:
Numéro de catalogue:CM1076470
Poids moléculaire:509.41
Point d'ébullition:
N° Mdl:
Stockage:

Category Infos

PROTAC-E3 Ligase Ligands
Bifunctional degrader molecules, also called proteolysis-targeting chimeras (PROTACs), are a new modality of chemical tools and potential therapeutics to understand and treat human disease. A required PROTAC component is a ligand binding to an E3 ubiquitin ligase, which is then joined to another ligand binding to a protein to be degraded via the ubiquitin–proteasome system. The advent of nonpeptidic small-molecule E3 ligase ligands revolutionized the field and ushered in the design of drug-like PROTACs with potent and selective degradation activity.
PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules
Proteolysis-Targeting Chimeras | PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules
PROTAC (Proteolysis-Targeting Chimeras) is a promising approach in drug discovery that involves the use of small molecules to target specific proteins for degradation by the cellular machinery.